BUSINESSCNBC TOP
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways
Johnson & Johnson's quarterly performance beat and raised estimates, though the stock price fell. Analysts cite sufficient positive factors to justify maintaining stock ownership and raising the price target.
Mentioned
Related Signal
Adjacent reporting
- We're raising our price target on Nvidia after another knockout quarter and guide
- Johnson & Johnson posted stronger-than-expected earnings and raised its full-year outlook
- Why we're raising our price target on Broadcom despite its post-earnings sell-off
- Oracle beats on earnings, but stock drops on plans to raise another $20 billion
- We're upping our Palo Alto price target after strong earnings vanquish AI disruption fears